Clinical Trials Browser

Interventional × Pain, Intractable × 90 days × Clear all

NCT02522611 2026-06-01

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Phase 1/2 Not yet recruiting

Cancer Pain, Pain, Intractable

NCT00804154 2026-05-01

Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

Phase 1 Recruiting

Cancer Pain, Pain, Intractable